# A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

> **NCT04075916** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 201 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Epclusa

## Key facts

- **NCT ID:** NCT04075916
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-22
- **Primary completion:** 2025-07-15
- **Final completion:** 2026-02-25
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04075916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04075916, "A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04075916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*